Tuberculosis Testing Market Expected to Reach USD 2.62 Billion Globally in 2020

According to a new market report published by Transparency Market Research “Tuberculosis Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,” the global tuberculosis testing market was valued at USD 1,936.1 million in 2013 and is expected to grow at a CAGR of 4.3% from 2014 to 2020, to reach an estimated value of USD 2,619.4 million in 2020.

Tuberculosis (TB) accounts for a large share of the global infectious disease burden. The disease was most widespread between 1950s and 1960s across the world and the WHO declared TB as a global emergency in 1993. However, due to the continuous and effective control measures and programs such as Stop TB and DOTS (Directly Observed Treatment, Short-course) most developed nations have been able to minimize the spread of this disease. Tuberculosis is still highly prevalent in many parts of the world affecting millions of lives, especially in Asia and Africa.

TB is a highly contagious disease and is the second leading cause of death, after human immunodeficiency virus (HIV). Active tuberculosis and latent tuberculosis are the two most common forms of TB that affect individuals. Over the time, TB has also developed into more diverse and potent forms that are referred as multi-drug resistant (MDR) or extensively drug resistant (XDR) TB. These conditions are also spreading at a rapid rate and require extensive diagnostic and treatment measures to check its spread worldwide. Various tuberculosis testing procedures and equipment are currently available in the global market. Improved and technologically advanced TB testing techniques such as IGRA, rapid TB tests, serological tests, etc. have made diagnosis more accurate, reliable, quick and easy to use.

Some of the major commercially available TB tests include culture tests, nucleic acid tests, tuberculin skin tests, sputum smear microscopy, chest X-ray and drug susceptibility testing. Culture-based TB tests were the largest segment in terms of revenue of the global TB testing market, valued at USD 691.2 million in 2013. Factors such as high sensitivity, accuracy and reliability of culture-based TB tests over other TB tests such as smear microscopy, Mantoux test and chest radiography have been attributed to the higher market share of the segment.

According to the WHO estimates, over nine million people suffered from tuberculosis in 2013 worldwide. The total number of TB cases increased by approximately 4.7% from 8.6 million cases in 2012 to 9 million in 2013 globally. The high prevalence and incidence of TB, availability of various new and improved tests, growing awareness levels, developing healthcare infrastructure and improving purchasing power of the general population are the major factors responsible for the growth of tuberculosis testing market. In addition, increased involvement of some of the world’s leading organizations such as the WHO and FIND (Foundation for Innovative New Diagnostics) for the development of new TB diagnostic tests is also responsible for the growth of the TB testing market. For instance, the WHO, through its Stop TB initiative, has provided the world with a vision to eradicate TB by 2050. On the other hand, factors such as lack of specificity, high cost associated with testing procedure and requirement of specialized equipment might hinder the growth of tuberculosis testing market. Besides these facts, the TB diagnostics market is observed to be a promising prospect in the near future as many new product developers and manufacturers are expected to venture into the market with a robust pipeline of testing technologies.

Geographically, the global market for tuberculosis testing has been segmented into four major markets, namely, North America, Europe, Asia Pacific, and Rest of the World (RoW). Asia Pacific accounted for a majority share, i.e. over 35% of the overall tuberculosis testing market in 2013. The major share of Asia Pacific is attributed to the presence of vast patient pool and very high incidence rate of TB. North America is the second largest market for tuberculosis testing in terms of revenue followed by Europe. Major Western European economies such as the U.K., Germany, France, Spain and Italy are the key contributing nations towards the overall tuberculosis testing market revenue in the region.

Browse the full Tuberculosis Testing Market (Smear Microscopy, Culture Based Tests, Nucleic Acid Testing, Mantoux Test, Radiography (Chest X-Ray), Drug Susceptibility Testing (DST) and Other TB Tests): Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 report at http://www.transparencymarketresearch.com/tuberculosis-testing-market.html

Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche, Ltd., Hain Lifescience GmbH, bioMérieux SA, Hologic, Inc., QIAGEN, Akonni Biosystems, Inc., Abbott Laboratories, Alere, Inc., Cepheid, Epistem, Plc. and Sanofi are some of the major players operating in the global tuberculosis testing market. Among these Becton, Dickinson and Company or BD, Thermo Fisher Scientific, Inc, F. Hoffmann-La Roche Ltd. and Hain Lifescience GmbH dominate the global tuberculosis testing market.

 

The global tuberculosis testing market is segmented as follows:

Tuberculosis Testing Market, by Test Type

Smear Microscopy

Culture Based Tests

Nucleic Acid Testing

Mantoux Test (Tuberculin Skin Test)

Radiography (Chest X-Ray)

Drug Susceptibility Testing (DST)

Other Tests (Serological Tests, IGRA, ADA, etc.)

Tuberculosis Testing Market, by Geography

North America

Europe

Asia Pacific

Rest of the World (RoW)

Request a Brochure of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=2267

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.